Aurinia Pharmaceuticals Inc - Common Shares — Bilan (NASDAQ:AUPH) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 463.66 M543.37 M470.86 M548.06 M550.64 M751.59 M Total du passif 55.91 M64.28 M65.42 M170.11 M173.17 M170.26 M Total des capitaux propres 407.75 M479.09 M405.44 M377.95 M377.48 M581.33 M Total du passif et des capitaux propres 463.66 M543.37 M470.86 M548.06 M550.64 M751.59 M Dette totale —————— Dette nette ——————

Nouvelles

Kezar Life Sciences acquise par Aurinia Pharma U.S. ; radiation du NASDAQ

Aurinia Pharmaceuticals finalise l’acquisition de Kezar Life Sciences

Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates

Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates

Select Medical (SEM) Lags Q1 Earnings Estimates

Résultats d’Aurinia à venir : la nouvelle direction peut-elle maintenir la croissance ?

ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock?

Arm, At Heart Of The AI Megatrend, Leads 12 Hot Prospects To Best Stock Watchlists

Casey's Hits Record High Amid Rapid Expansion. Leads 11 To Best Stock Lists.

ESCO Technologies Stock, PayPay, Amer Sports Among 18 New Stocks On IBD Watchlists

Agnico Eagle Mines Stock, CF Industries, 8 Others Enter IBD Watchlists

ASML Stock, Astera Labs Among 15 New Stocks On IBD Watchlists